Annotation Detail

Information
Associated Genes
PIK3CA
Associated Variants
PIK3CA p.Glu542Lys (p.E542K) ( ENST00000643187.1, ENST00000263967.4 )
PIK3CA p.Glu542Lys (p.E542K) ( ENST00000263967.4, ENST00000643187.1 )
Associated Disease
colorectal cancer
Source Database
CIViC Evidence
Description
PIK3CA mutation status was not predictive of response to regorafenib treatment in patients that had received standard therapy and progressed within 3 months of their last treatment.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/83
Gene URL
https://civic.genome.wustl.edu/links/genes/37
Variant URL
https://civic.genome.wustl.edu/links/variants/103
Rating
4
Evidence Type
Predictive
Disease
Colorectal Cancer
Evidence Direction
Does Not Support
Drug
Regorafenib
Evidence Level
B
Clinical Significance
N/A
Pubmed
24559322
Drugs
Drug NameSensitivitySupported
RegorafenibN/Afalse